uniQure (QURE) Invested Capital (2015 - 2024)
uniQure's (QURE) quarterly Invested Capital came in at $29.2 million in Q3 2024, up 9.36% year-on-year from $26.7 million in Q4 2023, and up 4.06% quarter-over-quarter from $28.1 million in Q2 2024.
uniQure (QURE) Invested Capital (2015 - 2024) Analysis & Trends
uniQure's Invested Capital history runs 7 years deep, the most recent figure standing at $29.2 million for Q3 2024.
- On a quarterly basis, Invested Capital rose 9.36% year-over-year to $29.2 million in Q3 2024; TTM through Jun 2025 was $29.2 million, a 73.59% decrease from a year earlier, with the FY2023 full-year figure at $28.2 million, up 8.58% from the prior year.
- Invested Capital advanced to $29.2 million in Q3 2024 per QURE's latest filing, from $28.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $29.2 million in Q3 2024 and bottomed at $8.7 million in Q2 2022.
- The 3-year median for Invested Capital is $27.3 million (2023), against an average of $23.8 million.
- Across the five-year window, Invested Capital soared 218.7% in 2023 and grew 1.05% in 2024, its largest moves.
- Year by year, Invested Capital stood at $26.0 million in 2022, then increased by 8.58% to $28.2 million in 2023, then gained by 3.51% to $29.2 million in 2024.
- Per Business Quant, the three latest QURE Invested Capital figures stand at $29.2 million (Q3 2024), $28.1 million (Q2 2024), and $27.6 million (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn | 116.14 Mn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | - |
| 10 | uniQure | 2.44 Bn | 2.44 Bn | 3.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 29.20 Mn |
| Jun 30, 2024 | 28.06 Mn |
| Mar 31, 2024 | 27.59 Mn |
| Dec 31, 2023 | 28.21 Mn |
| Sep 30, 2023 | 26.70 Mn |
| Jun 30, 2023 | 27.67 Mn |
| Mar 31, 2023 | 27.30 Mn |
| Dec 31, 2022 | 25.98 Mn |
| Sep 30, 2022 | 23.50 Mn |
| Jun 30, 2022 | 8.68 Mn |
| Mar 31, 2022 | 9.10 Mn |
| Sep 30, 2018 | 11.11 Mn |
| Jun 30, 2018 | 8.03 Mn |
| Mar 31, 2018 | 1.15 Mn |
| Dec 31, 2017 | 1.05 Mn |
| Sep 30, 2017 | 1.02 Mn |
| Jun 30, 2017 | 4.32 Mn |
| Mar 31, 2017 | 2.44 Mn |
| Dec 31, 2016 | 605,000.00 |
| Dec 31, 2015 | 5.58 Mn |